Pfizer allows 95 nations to make its COVID-19 pill, 53% of world's population likely to benefit

Pfizer allows 95 nations to make its COVID-19 pill, 53% of world's population likely to benefit

DNA

Published

Pfizer's clinical trials suggest COVID-19 pill cuts the risk of hospitalisation or death by 89% in non-hospitalised high-risk adults with coronavirus.

Full Article